Republic of Ireland & Republic of Ireland — Health Service Executive

Republic of Ireland: The Republic of Ireland is responsible for Budget 2027 and will decide whether to allocate the €3 million. The decision reflects its commitment to addressing homelessness and healthcare pressures, with potential implications for public spending and social policy.

Republic of Ireland — Health Service Executive: The Republic of Ireland — Health Service Executive is conducting a review of the facility that will inform the business case for expansion. Its findings will influence the government's funding decision, but the review itself does not directly affect its financial position.

Republic of Ireland: Country where the drug approval dispute is occurring; the outcome may affect healthcare policy.

Republic of Ireland — Health Service Executive: HSE Drugs Group did not recommend Skyclarys for reimbursement, referring it to an expert committee.

Republic of Ireland: Country where the funding decision is being made, affecting about 200 patients.

Republic of Ireland — Health Service Executive: The HSE Drugs Group recommended against funding Skyclarys, citing efficacy and cost concerns; final decision pending.

Republic of Ireland: Government faces pressure to reform public sector staffing; the Mid-Year Expenditure Report informs budget decisions.

Republic of Ireland — Health Service Executive: HSE is the main target of criticism for imbalanced staffing growth; may face restructuring.

Republic of Ireland: Republic of Ireland is one of the international markets where CannEpil is available through its Medicinal Cannabis Access Program (MCAP) and supported by reimbursement mechanisms.

Republic of Ireland — Health Service Executive: Republic of Ireland — Health Service Executive in Republic of Ireland administers reimbursement mechanisms that support CannEpil's eligibility under the Medicinal Cannabis Access Program (MCAP).

Republic of Ireland — Health Service Executive: The Republic of Ireland — Health Service Executive reported disruption to medical appointments, home care, and critical treatments due to the fuel protests, warning of impacts on time-sensitive medicine deliveries.

Republic of Ireland — Health Service Executive: The Republic of Ireland — Health Service Executive is issuing a renewed warning about the dangers of sunbed use, particularly targeting young people due to misinformation circulating online.

Republic of Ireland — Health Service Executive: The Republic of Ireland — Health Service Executive>>> is the primary management body involved in the dispute, facing criticism for not implementing a 2020 review and failing to resolve the pay dispute with ambulance workers. Its services are significantly impacted by the industrial action.